118 related articles for article (PubMed ID: 7551263)
1. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
Oyama T; Mitsudomi T; Mizoue T; Ohgami A; Osaki T; Nakanishi R; Yasumoto K
Surg Oncol; 1995; 4(2):83-9. PubMed ID: 7551263
[TBL] [Abstract][Full Text] [Related]
2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar organizer regions are independently associated with a shortened survival in patients with non-small cell lung cancer.
Oyama T; Mitsudomi T; Yoshida Y; Mizoue T; Hamada T; Shirakusa T
Surg Oncol; 1993 Dec; 2(6):341-7. PubMed ID: 8130941
[TBL] [Abstract][Full Text] [Related]
5. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1996 Mar; 27(3):240-7. PubMed ID: 8600037
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of different biomarkers in non-small cell lung cancer.
Lavezzi AM; Santambrogio L; Bellaviti N; Biondo B; Nosotti M; Radice F; Matturri L
Oncol Rep; 1999; 6(4):819-25. PubMed ID: 10373663
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen and argyrophilic nucleolar organizer regions in patients with thymic disease.
Oyama T; Osaki T; Mitsudomi T; Mizoue T; Ohgami A; Nakanishi R; Sugio K; Yasumoto K
Oncol Rep; 1997; 4(6):1201-5. PubMed ID: 21590222
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
12. PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.
Morisaki Y; Shima S; Yoshizumi Y; Sugiura Y; Tanaka S; Tamai S
Surg Today; 1995; 25(5):389-95. PubMed ID: 7640465
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas.
Yue L; Iwai M; Furuta I
Oral Oncol; 1999 Jan; 35(1):70-6. PubMed ID: 10211313
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer.
Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
Eur J Surg Oncol; 1995 Aug; 21(4):368-73. PubMed ID: 7664900
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of nucleolar organizer region, proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours.
Shimada N; Suzuki J; Fujita J; Kawakami Y; Tsukakoshi H; Hosokawa M; Sato N
J Gastroenterol Hepatol; 1998 Aug; 13(8):794-800. PubMed ID: 9736172
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
Suzuki T; Takano Y
Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
Kakeji Y; Maehara Y; Adachi Y; Baba H; Mori M; Furusawa M; Sugimachi K
Br J Cancer; 1994 Apr; 69(4):749-53. PubMed ID: 7908217
[TBL] [Abstract][Full Text] [Related]
20. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
